Please login to the form below
melanoma
This page shows the latest melanoma news and features for those working in and with pharma, biotech and healthcare.
CHMP recommends new Keytruda dosing schedule
It will be applied across all eight of Keytruda’s monotherapy indications in five tumour types, including non-small cell lung cancer (NSCLC), melanoma, bladder cancer, head and neck cancer and
Latest news
-
AZ signs $20m deal with Seres for microbiome project
improve the clinical outcomes of metastatic melanoma patients treated with currently-available immunotherapies.
-
Novartis and Syncona back new Swiss biotech Anaveon
Novartis’ Proleukin is a human-IL-2 based medicine that’s already approved in the US and EU for the treatment of metastatic melanoma and renal cancer, but despite its success,
-
Innovent gears up for PD-1 inhibitor launch in China
1 inhibitor Tuoyi (toripalimab) for melanoma. ... melanoma the following month.
-
Novartis aims for 10 blockbuster launches by 2020
OMB157 – relapsing MS. PDR001 combo – metastatic melanoma. QMV149 – asthma.
-
BMS isn’t phased by Opdivo’s slowing growth – for now
is still anticipating solid growth for the drug “in the US and internationally” in 2019 thanks to new indications such as adjuvant melanoma and first-line kidney cancer.
More from news
Approximately 78 fully matching, plus 268 partially matching documents found.
Latest Intelligence
-
Immuno-oncology in 2019: the rapid evolution continues
BMS led the charge when Opdivo became the first in its class to gain approval (in metastatic melanoma in December 2014 in Japan), but Merck &Co’s Keytruda has emerged as
-
Is China ready for a pharmaceutical gold rush?
China’s millions of tobacco smokers make for a large market, which may be why BMS filed for approval in lung cancer treatment, rather than melanoma, the leading indication in other
-
Combined immunotherapies – potential and pitfalls
The recent failed phase 3 trial of a combination of MSD’s monoclonal antibody Keytruda (pembrolizumab) and InCyte Corporation’s epacadostat in metastatic melanoma is a case in point he says.
-
Cancer immunotherapy: What's on the horizon?
had transformative results in some diseases such as melanoma, non-small cell lung cancer and bladder cancer – among others. ... Cavatak is now in three trials in melanoma, bladder cancer and NSCLC that are due to generate results in 2018/2019.
-
Communication is the key to unlocking the potential of immuno-oncology
Decades later, in a twist of presidential fate, 92-year old fellow US President Jimmy Carter received his all clear from melanoma thanks in part to an entirely new way to
More from intelligence
Approximately 0 fully matching, plus 16 partially matching documents found.
Latest appointments
-
Industry appointments
Most recently, Hassan built the oncology-focused biology, preclinical and biomarker units for Immunocore, overseeing early development and the first-in-human trial of a TCR based biologic targeting a melanoma
-
Packer Forbes appoints Jade McCudden
McCudden has worked across a number of disease areas including hepatitis C, anticoagulation, Alzheimer's disease, women's health, melanoma and nicotine replacement therapy.
-
Array appoints Victor Sandor chief medical officer
This includes the Colorado, US-based company's binimetinic, a MEK inhibitor in phase III trials for ovarian cancer and melanoma, and filanesib, a KSP inhibitor for multiple myeloma.
-
Bruno Strigini leaves Merck & Co for Novartis
Leading the field though is Strigini's former company Merck &Co, which has already filed MK-3475 in the US to treat advanced melanoma.
-
Chris Bowden joins Agios
During this time he worked on major cancer medicines, such as melanoma drug Zelboraf (vemurafenib) and Erivedge (vismodegib) for patients with unresectable, locally advanced or metastatic basal cell carcinoma.
More from appointments
Approximately 0 fully matching, plus 6 partially matching documents found.
Latest from PMHub
-
Artificial Intelligence in Healthcare
It missed fewer melanomas, meaning it had a higher sensitivity, and it misdiagnosed fewer benign moles as malignant melanoma, meaning it also had a higher specificity.[15]. ... Man against machine: diagnostic performance of a deep learning convolutional
-
Immunotherapies in oncology: the future of cancer treatment lies in combinations and partnerships
Yervoy (ipilimumab, Bristol-Myers Squibb) is a first-generation agent which was approved by the FDA in 2011 for advanced melanoma.
-
Therapy Watch expands oncology and IBD portfolios
Therapy Watch CML is part of a wider oncology portfolio which already covers Chronic Lymphocytic Leukaemia (CLL), Non-Hodgkin's Lymphoma (NHL), Melanoma, Non-Small Cell Lung Cancer (NSCLC), Prostate Cancer
-
Therapy Watch expands its oncology portfolio
Therapy Watch SCCHN is part of a wider portfolio which covers Chronic Lymphocytic Leukaemia (CLL), Non-Hodgkin's Lymphoma (NHL), Melanoma, Non-Small Cell Lung Cancer (NSCLC), Prostate Cancer (PCa), Renal
-
Why patient education is important in oncology
We talked to Dr Bettina Ryll of Melanoma Patient Network Europe about changes in melanoma treatment and how the added complexity of new treatments has changed how patients need to be ... Therefore, the Melanoma Patient Network Europe has a heavy focus on
More from PMHub
Approximately 1 fully matching, plus 9 partially matching documents found.
Featured jobs
-
Creative/ Medical Writer
-
Circa £35, 000 With Benefits
- Associate Director – Social Healthcare – London
-
HIGHLEY COMPETATIVE SALARY, BONUS &BENEFITS
- Account Manager, Medical Communications and Marketing
-
£30, 000 – £40, 000 benefits and bonus
- Freelance AM/ AD Healthcare Advertising
-
£350-400 depending on experience
- Science Writer, Healthcare Advertising Agency
-
£40, 000 - 45, 000 DOE benefits,
- Senior Account Manager, Medical Communications, London
-
Excellent package
- Scientific Director – Medical Communications - New York or Remot...
-
$100000 - $150000
- Home based, Senior Medical Writer, Medical Communications
-
Excellent package
- EU Head of Business Development and Client Service
-
Exceptional packge and bonus
- Home-based Senior Medical Writer – Med Ed
-
Salary TBC
- Scientific Director – Medical Communications
-
Salary TBC
-
Account Director, Medical Education
-
Salary TBC
-
Health Consultant - Brand Comms
-
Competitive Salary
-
Digital Account Director
-
Salary TBC
Subscribe to our email news alerts
PMHub
Videum Health
Videum Health is a premium video platform that offers brands innovative engagement strategies to reach targeted healthcare audiences on a...
Latest intelligence
- Measures for measures
- Why pharma’s marketing metrics must close the loop...
- Where next in Alzheimer’s disease R&D?
- How past failures and emerging biology are reshaping drug development...
- Brain power: fresh approaches to Alzheimer’s drug discovery
- New alliances are learning from past mistakes and breaking down research barriers...
Quick links
Infographics
